Datasets:

Shishir1807
/

test_drug

+instruction,input,output
+Identify mentioned drugs from the abstract title,Baseline GP2 immune response as an independent prognostic factor in a phase IIb study evaluating HER2/neu peptide GP2 (GLSI-100) versus. GM-CSF alone after adjuvant trastuzumab in HER2-positive women with breast cancer.,GLSI-100;;GM-CSF
+Identify mentioned drugs from the abstract title,Development of radiolabelled plerixafor as a theranostic tool for malignant lymphomas,Plerixafor
+Identify mentioned drugs from the abstract title,12-year trend in utilization of IVIG and plasmapheresis following acute myasthenia exacerbation and myasthenic crisis in the United States and their association with outcome.,IVIG
+Identify mentioned drugs from the abstract title,Deep Immune Profiling in Multiple Myeloma at Diagnosis and Under Lenalidomide Maintenance Therapy,Lenalidomide
+Identify mentioned drugs from the abstract title,"Anlotinib plus chemotherapy as neoadjuvant treatment of high-risk, early-stage triple-negative breast cancer: A prospective, single-arm, single-center, phase II clinical study.",anlotinib
+Identify mentioned drugs from the abstract title,"Assessment of Dose Proportionality of Three Dose Strengths (6 mg, 12 mg and 24 mg) over the Clinical Dose Range (6-48 mg) of the Newly Developed Once-Daily Extended Release Tablet Formulation of Deutetrabenazine",Deutetrabenazine
+Identify mentioned drugs from the abstract title,"Apatinib Combined With Irinotecan in the Treatment of Small Cell Lung Cancer: A Phase 2, Single-Arm, Prospective Study",Apatinib;;Irinotecan
+Identify mentioned drugs from the abstract title,CISH gene-knockout anti-CD70-CAR NK cells demonstrate potent anti-tumor activity against solid tumor cell lines and provide partial resistance to tumor microenvironment inhibition,Anti-CD70-CAR NK Cell
+Identify mentioned drugs from the abstract title,"A Retrospective Comparison of Survival Outcomes in EGFR-mutated, NSCLC Patients on Osimertinib +/- Brain Metastases",Osimertinib
+Identify mentioned drugs from the abstract title,Cisplatin versus mitomycin plus fluoropyrimidine and radiation for localized squamous cell carcinoma of the anus (SCCA) - final results of GTG-LACOG 1318 real world data study,Cisplatin;;Mitomycin
+Identify mentioned drugs from the abstract title,CCRL2 affects the sensitivity of MDS and secondary AML to azacitidine,Azacitidine
+Identify mentioned drugs from the abstract title,"A Study of ALPN-202, a PD-L1-dependent CD28 costimulator and dual checkpoint inhibitor, in combination with pembrolizumab in patients with advanced malignancies",ALPN-202;;Pembrolizumab
+Identify mentioned drugs from the abstract title,A common gut commensal utilizes tryptophan to promote cancer via the aryl hydrocarbon receptor,Tryptophan
+Identify mentioned drugs from the abstract title,Adjuvant chemotherapy in ypStage III locally advanced rectal cancer after neoadjuvant treatment with an oxaliplatin-based regimen.,Oxaliplatin
+Identify mentioned drugs from the abstract title,Brentuximab Vedotin Plus ESHAP (BRESHAP) Versus ESHAP As Salvage Strategy for Patients with Primary Refractory or Relapsed Classical Hodgkin's Lymphoma. Preliminary Results from the Breselibet Prospective Clinical Trial,Brentuximab Vedotin;;ESHAP;;ESHAP
+Identify mentioned drugs from the abstract title,A phase 2 study of neoadjuvant lenvatinib in locally advanced invasive thyroid cancer.,Lenvatinib
+Identify mentioned drugs from the abstract title,A WT1 oral cancer vaccine using a Bifidobactrerium vector suppresses growth of anti-PD-1 antibody-resistant mouse bladder tumor,WT1 Cancer Vaccine
+Identify mentioned drugs from the abstract title,3-year update of neoadjuvant atezolizumab + chemotherapy in patients with resectable non-small cell lung cancer,Atezolizumab
+Identify mentioned drugs from the abstract title,Degree Of Cell Packing Of Cryopreserved At -80oC Hematopoietic Stem Cells Does Not Affect Their Viability And Hematologic Recovery Of Transplanted Myeloma Patients,Hematopoietic Stem Cell
+Identify mentioned drugs from the abstract title,CCTG PR21: A randomized phase II study of [177lu]lu-PSMA-617 verus docetaxel in patients with metastatic castration-resistant prostate cancerand PSMA-positive disease (NCT04663997).,[177-Lu]Lu-PSMA-617;;Docetaxel
+Identify mentioned drugs from the abstract title,"A Phase 1, First in Human (FIH) study of autologous macrophages containing an anti-HER2 chimeric antigen receptor (CAR) in participants with HER2 overexpressing solid tumors.",Anti-HER2 CAR Macrophage
+Identify mentioned drugs from the abstract title,CD8 T cell-melanoma cell interactions in response and resistance to ipilimumab plus nivolumab: Biopsy analysis of SWOG S1616,Ipilimumab;;Nivolumab
+Identify mentioned drugs from the abstract title,"Central Memory T-Cell Differentiation Correlates with Depth of Response in Relapsed/Refractory Multiple Myeloma Patients Receiving Elotuzumab in Combination with Carfilzomib, Lenalidomide and Dexamethasone (Elo-KRd)",Carfilzomib;;Dexamethasone;;Elotuzumab;;Lenalidomide
+Identify mentioned drugs from the abstract title,Biomarkers of Clinical Resistance to Decitabine and Venetoclax Therapy Inferred By Transcriptome and Methylation Analyses,Decitabine;;Venetoclax
+Identify mentioned drugs from the abstract title,Beyond PACIFIC: Real-world outcomes of adjuvant durvalumab according to treatment received and PD-L1 expression,Durvalumab
+Identify mentioned drugs from the abstract title,Comparison of Fludarabine/Melphalan (FluMel) with Fludarabine/Melphalan/BCNU or Thiotepa (FBM/FTM) in Patients with AML in First Complete Remission Undergoing Allogeneic Hematopoietic Stem Cell Transplantation - a Registry Study on Behalf of the EBMT Acute Leukemia Working Party,Fludarabine;;Melphalan;;Thiotepa;;BCNA;;Fludarabine;;Melphalan;;Thiotepa
+Identify mentioned drugs from the abstract title,"ARTO trial (NCT03449719), a randomized phase II trial enrolling oligometastatic castration-resistant prostate cancer patients treated with first-line abiraterone acetate with or without stereotactic body radiation therapy: Preliminary results comprehensive of biochemical outcomes and circulating tumor cells analysis.",Abiraterone Acetate
+Identify mentioned drugs from the abstract title,Updates on Abstract 388570: Landscape of Pathogenic Germline Variants in Patients with Lung Cancer.,
+Identify mentioned drugs from the abstract title,A switch in mechanism of action attenuates doxorubicin-mediated cardiotoxicity,Doxorubicin
+Identify mentioned drugs from the abstract title,Adherence to and patient satisfaction with the combination therapy of exemestane and everolimus in postmenopausal women with HR+ HER2- advanced breast cancer: Results from the IPSOC-mamma study,Everolimus;;Exemestane
+Identify mentioned drugs from the abstract title,Cannabidiol in anxiety research – a translational integration of preclinical and clinical studies,Cannabidiol
+Identify mentioned drugs from the abstract title,"Delay of Aspirin Administration in patients after Stroke Code Activation, who are not candidates for tissue Plasminogen Activator (t-PA) or Mechanical Thrombectomy (MT) pre- and post-COVID pandemic.",Aspirin
+Identify mentioned drugs from the abstract title,A phase 1b study of nivolumab in patients with autoimmune disorders and advanced malignancies (AIM-NIVO),NIVO;;Nivolumab
+Identify mentioned drugs from the abstract title,Desmopressin is twice effective in females: A systematic review and meta-analysis on medical treatment of nocturia,Desmopressin
+Identify mentioned drugs from the abstract title,Clinical and microbiological outcomes for Enterobacterales uropathogens in the Phase 3 ADAPT-PO Study of oral tebipenem pivoxil hydrobromide,Tebipenem Pivoxil Hydrobromide
+Identify mentioned drugs from the abstract title,"A randomized, pre-surgical study to investigate the biological effects of AZD9833 doses in women with ER-positive HER2-negative primary breast cancer (SERENA-3)",AZD-9833
+Identify mentioned drugs from the abstract title,"Bms-986158, A Potent Bet Inhibitor, As Monotherapy And In Combination With Ruxolitinib Or Fedratinib In Intermediate- Or High-Risk Myelofibrosis (Mf): Results From A Phase 1/2 Study",BMS-986158;;Fedratinib;;Ruxolitinib
+Identify mentioned drugs from the abstract title,"ASTX660, a non-peptidomimetic antagonist of cIAP1/2 and XIAP, enhances immune mediated tumor killing and induction of immunogenic cell death",ASTX-660
+Identify mentioned drugs from the abstract title,ARTISTRY-1: Nemvaleukin alfa monotherapy and in combination with pembrolizumab in patients (pts) with advanced solid tumors.,Nemvaleukin Alfa;;Pembrolizumab
+Identify mentioned drugs from the abstract title,BATF3/MYC axis drives hyper-proliferation of TET2 deficient CAR T cells,CAR T-cell
+Identify mentioned drugs from the abstract title,Activity of OSE-2101 in HLA-A2+ non-small cell lung cancer (NSCLC) patients after failure to immune checkpoint inhibitors (IO): Final results of Phase 3 Atalante-1 randomised trial,OSE-2101
+Identify mentioned drugs from the abstract title,A Phase I Study of CD19 Chimeric Antigen Receptor-T Cells Generated By the PiggyBac Transposon Vector for Acute Lymphoblastic Leukemia,CD19 CAR T-Cell
+Identify mentioned drugs from the abstract title,"An Open-Label, Multicenter, Phase 1/2 Clinical Trial of RP1 as a Single Agent and in Combination with Nivolumab in Patients with Solid Tumors [IGNYTE]",RP1;;Nivolumab
+Identify mentioned drugs from the abstract title,Adverse events and estimated costs with the combination of ipilimumab and nivolumab in metastatic melanoma patients.,Ipilimumab;;Nivolumab
+Identify mentioned drugs from the abstract title,A Phase 1B/2 Study Of Tp-0903 And Decitabine Targeting Mutant Tp53 And/Or Complex Karyotype In Patients With Untreated Acute Myeloid Leukemia (Aml) >= Age 60 Years: Final Results,Decitabine;;TP-0903
+Identify mentioned drugs from the abstract title,"D3L-001, a novel bispecific antibody targeting HER2 and CD47, demonstrates potent preclinical efficacy in solid tumors.",D3L-001
+Identify mentioned drugs from the abstract title,Chemotherapy and bevacizumab prescription in routine management of metastatic colorectal cancer in Uruguay: Is clinical practice following the evidence?,Bevacizumab
+Identify mentioned drugs from the abstract title,Allo-Hct In Myelofibrosis - Current And Future Trends,ALLO
+Identify mentioned drugs from the abstract title,A functional approach to identifying and engineering TCRs results in highly-potent and specific TCRs for TCR-T cell therapy,TCR-T Cell
+Identify mentioned drugs from the abstract title,The Role Of Treatment Strategy In Reducing The Disability Risk In Multiple Sclerosis,
+Identify mentioned drugs from the abstract title,68Ga-PSMA PET radiomics for the prediction of post-surgical ISUP grade in primary prostate cancer patients,68Ga-PSMA
+Identify mentioned drugs from the abstract title,"CRISPR/Cas9 gene-edited, allogeneic anti-CD83 CAR-T cells demonstrate potent activity in GvHD and AML tumor models",Anti-CD83 CAR-T Cell
+Identify mentioned drugs from the abstract title,"Anlotinib plus chemotherapy as first-line therapy for gastrointestinal tumor patients with unresectable liver metastasis: A multicenter, multicohort clinical trial (ALTER-G-001).",Anlotinib